{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T13:11:42Z","timestamp":1783775502511,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,11]]},"DOI":"10.7759\/cureus.112455","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:14:52Z","timestamp":1783772092000},"source":"Crossref","is-referenced-by-count":0,"title":["The Effect of Antihypertensive Medication Classes on the Hemodynamic Severity Parameters of Classical and Paradoxical Low-Flow, Low-Gradient Aortic Stenosis"],"prefix":"10.7759","author":[{"given":"Chelsea","family":"Grant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azhar","family":"Supariwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"77","author":"Otto CM","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, et al.. 2020 ACC\/AHA Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2021, 77:e25-e197. 10.1016\/j.jacc.2020.11.018","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp361","article-title":"Paradoxical low flow and\/or low gradient severe aortic stenosis despite preserved left ventricular ejection fraction: implications for diagnosis and treatment","volume":"31","author":"Dumesnil JG","year":"2010","unstructured":"Dumesnil JG, Pibarot P, Carabello B. Paradoxical low flow and\/or low gradient severe aortic stenosis despite preserved left ventricular ejection fraction: implications for diagnosis and treatment. Eur Heart J. 2010, 31:281-9. 10.1093\/eurheartj\/ehp361","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2018.01.020","article-title":"Management of patients with aortic valve stenosis","volume":"93","author":"Kanwar A","year":"2018","unstructured":"Kanwar A, Thaden JJ, Nkomo VT. Management of patients with aortic valve stenosis. Mayo Clin Proc. 2018, 93:488-508. 10.1016\/j.mayocp.2018.01.020","journal-title":"Mayo Clin Proc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.900027","article-title":"Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial","volume":"121","author":"Chan KL","year":"2010","unstructured":"Chan KL, Teo K, Dumesnil JG, Ni A, Tam J. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation. 2010, 121:306-14. 10.1161\/CIRCULATIONAHA.109.900027","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"79","author":"Heidenreich PA","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al.. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2022, 79:e263-421. 10.1016\/j.jacc.2021.12.012","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rosseb\u00f8 AB","year":"2008","unstructured":"Rosseb\u00f8 AB, Pedersen TR, Boman K, et al.. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008, 359:1343-56. 10.1056\/NEJMoa0804602","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jead067","article-title":"Changes in echocardiographic parameters over time in paradoxical low-flow low-gradient aortic stenosis","volume":"24","author":"Galian-Gay L","year":"2023","unstructured":"Galian-Gay L, Teixid\u00f3-Tur\u00e0 G, Casas G, et al.. Changes in echocardiographic parameters over time in paradoxical low-flow low-gradient aortic stenosis. Eur Heart J Cardiovasc Imaging. 2023, 24:1120-8. 10.1093\/ehjci\/jead067","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.668681","article-title":"Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival","volume":"115","author":"Hachicha Z","year":"2007","unstructured":"Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation. 2007, 115:2856-64. 10.1161\/CIRCULATIONAHA.106.668681","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.113.001695","article-title":"Natural history of paradoxical low-gradient severe aortic stenosis","volume":"7","author":"Maes F","year":"2014","unstructured":"Maes F, Boulif J, Pi\u00e9rard S, et al.. Natural history of paradoxical low-gradient severe aortic stenosis. Circ Cardiovasc Imaging. 2014, 7:714-22. 10.1161\/CIRCIMAGING.113.001695","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.09.080","article-title":"Low-gradient, low-flow severe aortic stenosis with preserved left ventricular ejection fraction: characteristics, outcome, and implications for surgery","volume":"65","author":"Tribouilloy C","year":"2015","unstructured":"Tribouilloy C, Rusinaru D, Mar\u00e9chaux S, et al.. Low-gradient, low-flow severe aortic stenosis with preserved left ventricular ejection fraction: characteristics, outcome, and implications for surgery. J Am Coll Cardiol. 2015, 65:55-66. 10.1016\/j.jacc.2014.09.080","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1590\/s0066-782x2005000400006","article-title":"[Blockade of renin-angiotensin system attenuates cardiac remodeling in rats undergoing aortic stenosis]","volume":"84","author":"Gon\u00e7alves G","year":"2005","unstructured":"Gon\u00e7alves G, Zornoff LA, Ribeiro HB, et al.. [Blockade of renin-angiotensin system attenuates cardiac remodeling in rats undergoing aortic stenosis]. Arq Bras Cardiol. 2005, 84:304-8. 10.1590\/s0066-782x2005000400006","journal-title":"Arq Bras Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2008.03.012","article-title":"A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosis","volume":"156","author":"Stewart RA","year":"2008","unstructured":"Stewart RA, Kerr AJ, Cowan BR, et al.. A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosis. Am Heart J. 2008, 156:348-55. 10.1016\/j.ahj.2008.03.012","journal-title":"Am Heart J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000000182","article-title":"Is blockade of the renin-angiotensin system able to reverse the structural and functional remodeling of the left ventricle in severe aortic stenosis?","volume":"65","author":"Helske-Suihko S","year":"2015","unstructured":"Helske-Suihko S, Laine M, Lommi J, Kaartinen M, Werkkala K, Kovanen PT, Kupari M. Is blockade of the renin-angiotensin system able to reverse the structural and functional remodeling of the left ventricle in severe aortic stenosis?. J Cardiovasc Pharmacol. 2015, 65:233-40. 10.1097\/FJC.0000000000000182","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2011.02522.x","article-title":"Angiotensin receptor blockers are associated with a lower remodelling score of stenotic aortic valves","volume":"41","author":"C\u00f4t\u00e9 N","year":"2011","unstructured":"C\u00f4t\u00e9 N, Couture C, Pibarot P, Despr\u00e9s JP, Mathieu P. Angiotensin receptor blockers are associated with a lower remodelling score of stenotic aortic valves. Eur J Clin Invest. 2011, 41:1172-9. 10.1111\/j.1365-2362.2011.02522.x","journal-title":"Eur J Clin Invest"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12169","article-title":"Impact of hypertension and renin-angiotensin system inhibitors in aortic stenosis","volume":"43","author":"Capoulade R","year":"2013","unstructured":"Capoulade R, Clavel MA, Mathieu P, et al.. Impact of hypertension and renin-angiotensin system inhibitors in aortic stenosis. Eur J Clin Invest. 2013, 43:1262-72. 10.1111\/eci.12169","journal-title":"Eur J Clin Invest"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.01.063","article-title":"Impact of renin-angiotensin system blockade therapy on outcome in aortic stenosis","volume":"58","author":"Nadir MA","year":"2011","unstructured":"Nadir MA, Wei L, Elder DH, et al.. Impact of renin-angiotensin system blockade therapy on outcome in aortic stenosis. J Am Coll Cardiol. 2011, 58:570-6. 10.1016\/j.jacc.2011.01.063","journal-title":"J Am Coll Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2003.10.017","article-title":"Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: symptomatic cardiac obstruction-pilot study of enalapril in aortic stenosis (SCOPE-AS)","volume":"147","author":"Chockalingam A","year":"2004","unstructured":"Chockalingam A, Venkatesan S, Subramaniam T, et al.. Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: symptomatic cardiac obstruction-pilot study of enalapril in aortic stenosis (SCOPE-AS). Am Heart J. 2004, 147:E19. 10.1016\/j.ahj.2003.10.017","journal-title":"Am Heart J"},{"key":"ref18","article-title":"Aortic stenosis: diagnosis and treatment","volume":"93","author":"Grimard BH","year":"2016","unstructured":"Grimard BH, Safford RE, Burns EL. Aortic stenosis: diagnosis and treatment. Am Fam Physician. 2016, 93:371-8.","journal-title":"Am Fam Physician"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.117.006557","article-title":"Metoprolol reduces hemodynamic and metabolic overload in asymptomatic aortic valve stenosis patients: a randomized trial","volume":"10","author":"Hansson NH","year":"2017","unstructured":"Hansson NH, S\u00f6rensen J, Harms HJ, et al.. Metoprolol reduces hemodynamic and metabolic overload in asymptomatic aortic valve stenosis patients: a randomized trial. Circ Cardiovasc Imaging. 2017, 10:006557. 10.1161\/CIRCIMAGING.117.006557","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccl.2019.09.010","article-title":"Pathophysiology of aortic stenosis and future perspectives for medical therapy","volume":"38","author":"Zheng KH","year":"2020","unstructured":"Zheng KH, Tzolos E, Dweck MR. Pathophysiology of aortic stenosis and future perspectives for medical therapy. Cardiol Clin. 2020, 38:1-12. 10.1016\/j.ccl.2019.09.010","journal-title":"Cardiol Clin"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/506634-the-effect-of-antihypertensive-medication-classes-on-the-hemodynamic-severity-parameters-of-classical-and-paradoxical-low-flow-low-gradient-aortic-stenosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:14:53Z","timestamp":1783772093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/506634-the-effect-of-antihypertensive-medication-classes-on-the-hemodynamic-severity-parameters-of-classical-and-paradoxical-low-flow-low-gradient-aortic-stenosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.112455","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,11]]}}}